Bilir, C. Et Al. 2017. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study. CANCER INVESTIGATION , vol.35, no.4 , 248-255.

Bilir, C., Yildiz, I., Bilici, A., Ucar, M., Berk, V., Yildiz, Y., ... Yazici, O.(2017). Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study. CANCER INVESTIGATION , vol.35, no.4, 248-255.

Bilir, Cemil Et Al. "Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study," CANCER INVESTIGATION , vol.35, no.4, 248-255, 2017

Bilir, Cemil Et Al. "Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study." CANCER INVESTIGATION , vol.35, no.4, pp.248-255, 2017

Bilir, C. Et Al. (2017) . "Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study." CANCER INVESTIGATION , vol.35, no.4, pp.248-255.

@article{article, author={Cemil Bilir Et Al. }, title={Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study}, journal={CANCER INVESTIGATION}, year=2017, pages={248-255} }